190 related articles for article (PubMed ID: 26092622)
1. Prothrombin G20210A mutation and lower extremity peripheral arterial disease: a systematic review and meta-analysis.
Vazquez F; Rodger M; Carrier M; Le Gal G; Reny JL; Sofi F; Mueller T; Nagpal S; Jetty P; Gandara E
Eur J Vasc Endovasc Surg; 2015 Aug; 50(2):232-40. PubMed ID: 26092622
[TBL] [Abstract][Full Text] [Related]
2. Response to 'Re: Prothrombin G20210A Mutation and Lower Extremity Peripheral Arterial Disease. A Systematic Review and Meta-analysis'.
Vazquez F; Gandara E
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):827-8. PubMed ID: 26409705
[No Abstract] [Full Text] [Related]
3. Re: 'Prothrombin G20210 Mutation and Lower Extremity Peripheral Arterial Disease: A Systematic Review and Meta-analysis'.
Boulon C; Berard A; Freyburger G; Constans J
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):827. PubMed ID: 26384640
[No Abstract] [Full Text] [Related]
4. Thrombophilic risk factors and peripheral arterial disease severity.
Sartori M; Favaretto E; Legnani C; Cini M; Conti E; Amato A; Palareti G
Thromb Haemost; 2010 Jul; 104(1):71-7. PubMed ID: 20390230
[TBL] [Abstract][Full Text] [Related]
5. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies and lower extremity peripheral arterial disease - a systematic review and meta-analysis.
Gavier B; Vazquez F; Gandara E
Vasa; 2016; 45(4):325-30. PubMed ID: 27428502
[TBL] [Abstract][Full Text] [Related]
7. G20210A prothrombin mutation and critical limb ischaemia in patients with peripheral arterial disease.
Sartori M; Favaretto E; Legnani C; Cini M; Conti E; Pili C; Palareti G
Eur J Vasc Endovasc Surg; 2009 Jul; 38(1):113-7. PubMed ID: 19356951
[TBL] [Abstract][Full Text] [Related]
8. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
[TBL] [Abstract][Full Text] [Related]
9. Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls.
Krajcoviechova A; Wohlfahrt P; Mayer O; Vanek J; Hajkova J; Hlinovsky D; Kvasnicka T; Tremblay J; Hamet P; Filipovsky J; Kvasnicka J; Cifkova R
Atherosclerosis; 2015 Jun; 240(2):446-52. PubMed ID: 25897999
[TBL] [Abstract][Full Text] [Related]
10. Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis.
Chiasakul T; De Jesus E; Tong J; Chen Y; Crowther M; Garcia D; Chai-Adisaksopha C; Messé SR; Cuker A
J Am Heart Assoc; 2019 Oct; 8(19):e012877. PubMed ID: 31549567
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis.
Gonzalez JV; Barboza AG; Vazquez FJ; Gándara E
PLoS One; 2016; 11(3):e0151607. PubMed ID: 27031503
[TBL] [Abstract][Full Text] [Related]
12. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.
Qi X; Ren W; De Stefano V; Fan D
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1801-12.e7. PubMed ID: 24793031
[TBL] [Abstract][Full Text] [Related]
13. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
[TBL] [Abstract][Full Text] [Related]
14. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
15. Prothrombin G20210A mutation is associated with recurrent pregnancy loss: a systematic review and meta-analysis update.
Gao H; Tao FB
Thromb Res; 2015 Feb; 135(2):339-46. PubMed ID: 25528068
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
18. Lower extremity bypass for critical limb ischemia decreases major adverse limb events with equivalent cardiac risk compared with endovascular intervention.
Mehaffey JH; Hawkins RB; Fashandi A; Cherry KJ; Kern JA; Kron IL; Upchurch GR; Robinson WP
J Vasc Surg; 2017 Oct; 66(4):1109-1116.e1. PubMed ID: 28655549
[TBL] [Abstract][Full Text] [Related]
19. Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.
Rolla R; Pergolini P; Vidali M; Pollarolo P; Appiani A; Cerutti C; Manzini M; Crisci A; Bellomo G
Clin Lab; 2014; 60(10):1725-33. PubMed ID: 25651720
[TBL] [Abstract][Full Text] [Related]
20. The PORtromb Project: prothrombin G20210A mutation and venous thromboembolism in young people.
Mansilha A; Araújo F; Sampaio S; Cunha Ribeiro LM; Braga A
Cardiovasc Surg; 2002 Feb; 10(1):45-8. PubMed ID: 11790575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
